本页面由Tiger Trade Technology Pte. Ltd.提供服务

NEWAMSTERDAM PHARMA CO NV

20.19
-1.0600-4.99%
盘后:20.200.0100+0.05%19:30 EDT
成交量:98.97万
成交额:2,018.96万
市值:24.13亿
市盈率:-9.42
高:21.34
开:21.20
低:20.04
收:21.25
52周最高:42.21
52周最低:20.04
股本:1.20亿
流通股本:9,075.68万
量比:0.77
换手率:1.09%
股息:- -
股息率:- -
每股收益(TTM):-2.1442
每股收益(LYR):-1.7211
净资产收益率:-36.81%
总资产收益率:-20.11%
市净率:3.82
市盈率(LYR):-11.73

数据加载中...

2025/05/07

重要事件披露

Form 8-K - Current report
2025/04/17

重要事件披露

Form 8-K - Current report
2025/04/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

SEC问询函

Form CORRESP - Correspondence
2025/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/10

重要事件披露

Form 8-K - Current report
2025/01/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/12/17

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/17

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/17

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/13

重要事件披露

Form 8-K - Current report
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/10

重要事件披露

Form 8-K - Current report